antibiotic

Drug Price Legislation Faces Challenges

[vc_row][vc_column][rev_slider_vc alias="drug-legistlation"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]In May we released an article about a proposed rule coming down from CMS regarding drug prices in advertising. In June we noted that drug companies were fighting this rule in court. This month we see the setbacks and challenges the Trump Administration continue to face in lowering drug prices for the everyday American. On July 8, federal courts ruled that the Department of Health and Human Services (HHS)...

Donna White
Share
Prescription Benefits

CMS Final Rule for Drug Prices in Advertising

[vc_row][vc_column][rev_slider_vc alias="cms-final-drug-rule"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]A rule proposed in October of last year has become final on May 8, 2019. This rule would mandate that pharmaceutical companies publish the prices of any medication with a list price greater than $35 during television ads. Pharmaceutical companies tried to push back on this rule stating that listing the prices would confuse patients since what they pay will be different due to insurance coverage, rebates, and discounts....

Donna White
Share